The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application.

Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...

Ronald Schneider, B.S.Pharm., M.H.A.; Jonathan Bagby, R.N., M.B.A., M.S.N.; Russ Carlson, R.N., B.S.N., M.H.A. Am J Health Syst Pharm. 2008;65(23):2216-2219. In 1994 ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

BOSTON (SHNS) – Health officials are rolling out regulations to implement a 2024 law legalizing the use of certified medication aides in long-term care facilities, rules that supporters say will help ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Despite President Donald Trump’s claim, there’s no evidence the program had anywhere close to the effect he said it had — and experts say the measure weakened existing patient protections. Although ...

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.